Allurion Technologies (ALURD) Change in Receivables (2022 - 2026)

Allurion Technologies (ALURD) Change in Receivables (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 42.00 Mn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn -444.00 Mn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 287.00 Mn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 117.00 Mn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 117.90 Mn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn -141.00 Mn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn -124.60 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn -
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -365,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -365,000.00
Mar 31, 2026 -365,000.00
Dec 31, 2025 1.39 Mn
Dec 31, 2025 1.39 Mn
Sep 30, 2025 -865,000.00
Sep 30, 2025 -865,000.00
Jun 30, 2025 -2.25 Mn
Jun 30, 2025 -2.25 Mn
Mar 31, 2025 883,000.00
Mar 31, 2025 883,000.00
Dec 31, 2024 -1.78 Mn
Dec 31, 2024 -1.78 Mn
Sep 30, 2024 -2.79 Mn
Sep 30, 2024 -2.79 Mn
Jun 30, 2024 -2.74 Mn
Jun 30, 2024 -2.74 Mn
Mar 31, 2024 -1.67 Mn
Mar 31, 2024 -1.67 Mn
Dec 31, 2023 -2.57 Mn
Dec 31, 2023 -2.57 Mn